Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 September 2019

New Respiratory Disease Articles from our Partners at Consultant 360

How Long Does CVD Risk Remain After Quitting Smoking?

http://bit.ly/2ZvgqqP

Current cardiovascular risk calculators consider former smokers to be at risk for 5 years after quitting, but the actual time of elevated risk is unknown, according to researchers.

CDC Investigating Cases of Vaping-Related Severe Pulmonary Disease

http://bit.ly/2MI7Rmu

The CDC has begun investigating close to 100 cases of severe pulmonary disease associated with vaping/use of e-cigarettes in both adolescent and adult individuals.

Is Eosinophil-Guided Therapy Safe for Patients With COPD?

http://bit.ly/2ZwmQpO

Because systemic corticosteroids can have adverse effects in patients with acute exacerbations of COPD, authors of a new study assessed whether eosinophil-guided therapy could be a safer alternative.

Long-Term Exposure to Air Pollutants Increases Risk of Emphysema

http://bit.ly/2ztUduF

By studying more than 5700 participants from the MESA study, researchers identified the association between ambient air pollutants, emphysema progression, and lung function.

IPF Protein Treatment Is Tolerable in the Long Term

http://bit.ly/2HuF156

Researchers analyzed the long-term safety and tolerability of a recombinant human pentraxin 2 protein for the treatment of idiopathic pulmonary fibrosis.